USA endometrial cancer projections to 2030: should we be concerned?
about
Hormone replacement therapy for women previously treated for endometrial cancerThe End of the Hysterectomy Epidemic and Endometrial Cancer Incidence: What Are the Unintended Consequences of Declining Hysterectomy Rates?Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.A clinically applicable molecular-based classification for endometrial cancers.Features of omental adipose tissue in endometrial cancer patients with 'standard' or 'metabolically healthy' obesity: associations with tumor process characteristics.Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesityAn update on the current pharmacotherapy for endometrial cancer.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040.Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?Endometrial cancer: Not your grandmother's cancer.High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database.Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.Endometrial cancer evolution: new molecular-biologic types and hormonal-metabolic shifts.Renovated (nondual) approach to endometrial cancer typing: endocrine and inflammatory issues.Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients.Discovery of biomarkers for endometrial cancer: current status and prospects.The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females.Targeted therapy in endometrial cancer: Making progress.Association of Endometrial Cancer Risk With Postmenopausal Bleeding in WomenTargeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too LateThe miR-503 cluster is coordinately under-expressed in endometrial endometrioid adenocarcinoma and targets many oncogenes, cell cycle genes, DNA repair genes and chemotherapy response genesSteroid Receptor Coactivator-2 Controls the Pentose Phosphate Pathway through RPIA in Human Endometrial Cancer Cells
P2860
Q26471218-E2890493-AF0F-4D61-A0BF-A16194379DCDQ26752385-7523A316-A52A-4D4B-AE57-4B115EB98987Q33756429-DB861528-7D08-42FF-81E9-70C8A23BB812Q35863143-B5FBE315-1083-4218-B42F-51C15DF2E4C3Q37382304-F9FEFAC0-F0CF-45E0-8E10-16BE4022283CQ37474382-69CA80F4-43BB-472A-BB92-D0C564A0CB30Q38656675-8D9BB1A3-538E-4C03-AF4F-BBDD3E4644E6Q38788210-151C00AB-4BD9-48B2-89FE-CB3CBE63286EQ38810122-E8EEF213-1630-4018-B970-18F31F6692A7Q38831227-5D78E51C-9E9C-4561-B5EB-D6693277231DQ38852405-D31CD6FB-93F5-420C-A682-E3E71EE66DEDQ39290822-8688F42C-70DB-44A3-821B-C36FCB9C330DQ40524588-ED80B9C8-B455-4755-B3D1-C03F8B8BAF90Q47424270-F86D9027-EF97-4C92-B49D-7F97EA4EE59BQ48074431-3DEB8E95-82A5-4BEF-8B27-3115EE2BC349Q50128233-6F17957F-A207-458D-B153-4B28031040DBQ51341963-BD59CC88-4494-4D4E-8CA1-624539BEDC9DQ52715322-6A77017B-DACB-4B47-AF56-7292BC2926C1Q54171730-80D92A1F-5D8A-487A-8B69-816DB5490D48Q56028141-81AC72CB-4A3F-449D-B270-CDFD11F7E364Q57169683-C0FADDD3-8A12-4CB1-B5AD-F68AFF4B14BFQ58694641-E36EC042-4C48-4E67-9F6F-40A0B4C85C73Q58769245-035AA67D-409C-4EBD-A852-6060B1A48BFE
P2860
USA endometrial cancer projections to 2030: should we be concerned?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
USA endometrial cancer projections to 2030: should we be concerned?
@en
USA endometrial cancer projections to 2030: should we be concerned?
@nl
type
label
USA endometrial cancer projections to 2030: should we be concerned?
@en
USA endometrial cancer projections to 2030: should we be concerned?
@nl
prefLabel
USA endometrial cancer projections to 2030: should we be concerned?
@en
USA endometrial cancer projections to 2030: should we be concerned?
@nl
P2093
P2860
P356
P1433
P1476
USA endometrial cancer projections to 2030: should we be concerned?
@en
P2093
Andrew D Althouse
John Comerci
Joseph Kelley
Kyle E Freese
M Aamir Sheikh
Paniti Sukumvanich
Robert P Edwards
Ronald E LaPorte
Sean Soisson
Sharon Welburn
P2860
P304
P356
10.2217/FON.14.192
P407
P50
P577
2014-12-01T00:00:00Z